Table 2. Evaluation of cardiovascular risk and metabolic syndrome and erectile dysfunction.

	Group 1: control	Group 2: men with erectile dysfunction	P
Framingham risk score	7.76 ± 3.31	11.41 ± 8.33	0.0015
C-reactive protein	1.7 (1.9-3.7)	2.1 (3.1-5.1)	0.04
Metabolic syndrome	29/82 (26.1%)	53/58 (52.3%)	0.002